(S)-2-Amino-3-(3,4-difluorophenyl)propanoic acid is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of pharmaceutical compounds, particularly those targeting neurological and psychiatric disorders. Its structure is often incorporated into molecules designed to interact with specific receptors in the brain, such as those involved in the regulation of neurotransmitters. Additionally, it is explored for its potential in creating enantiomerically pure drugs, which can enhance efficacy and reduce side effects. Research also investigates its role in developing treatments for conditions like epilepsy, depression, and anxiety due to its ability to modulate biological pathways.